The Postoperative Pain Management market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It evaluates the current treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Postoperative Pain Management: An Overview
Postoperative pain is a normal response to surgical intervention and is a cause of delayed recovery and discharge after surgery or any other operative procedure, which also leads to increased risk of wound infection. Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finances. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.
Factors that cause the increment in the pain are location, type, and duration of the surgical procedure, type, and extent of the incision and surgical trauma, pain management before and after the surgical procedure, and others.
Get the PDF Sample of the Report:- https://www.delveinsight.com/sample-request/post-operative-pain-management-market
Postoperative Pain Management Market Key Facts
As per DelveInsight, the total number of cases in 2020 of postoperative pain in the 7MM was 66,426,881 which is expected to increase at a significant rate by 2032.
In 2020, the total number of patients with postoperative pain in the US was 40,618,489. The majority of the cases were of moderated type (44.50%).
In EU5, the number of cases were highest in Germany followed by France and the United Kingdom while the least number of cases were reported in Spain during the study period (2018–2032).
In 2020, Japan reported 1,22,49,558 cases of Postoperative pain, out of which there were 54,51,053 cases of moderate type.
According to the study by Presman et al. (2015), the combined calculated risk of pain or neuroma after abdominoplasty was 1.07%, with most localizing this pain to the abdominal wall.
According to a study by Thomazeau et al. (2016), out of the prospectively evaluated 104 knee replacement patients, 28.8% reported CPSP at 6 months.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Postoperative Pain Management market size and share by analyzing the impact of current and emerging therapies on the market. It also provides a detailed assessment of the unmet needs, market drivers barriers, and emerging technologies.
The report gives a thorough detail of the Postoperative Pain Management market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Postoperative Pain Management Epidemiology
The epidemiology section covers insights about the historical and current Postoperative Pain Management patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Postoperative Pain Management Epidemiology Subtype Segmentation
Total number of surgical procedures
Total number of Incident cases of Postoperative Pain
Severity-specific incident cases of Postoperative Pain
Surgical procedure-specific incident cases of Postoperative Pain (Colectomy, Abdominoplasty, Total Knee Replacement, Reduction mammoplasty, others)
Postoperative Pain Management Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Postoperative Pain Management market or expected to get launched in the market during the study period. The analysis covers Postoperative Pain Management market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Postoperative Pain Management Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
The current pipeline for postoperative pain holds many significant products being developed by some key players. The launch of the therapies is expected in the coming years.
Postoperative Pain Management Therapies covered in the market include:
TLC590 (ropivacaine with sustained-release delivery technology)
And many more
Some of the key companies in the Postoperative Pain Management Market include:
Taiwan Liposome Company
And many others
Get More Detailed Insights into the Emerging Therapies & Key Companies:- Chronic Insomnia Therapeutics Landscape
Table of Content
1. Key Insights
2. Executive Summary
3. Postoperative Pain Management Competitive Intelligence Analysis
4. Postoperative Pain Management Market Overview at a Glance
5. Postoperative Pain Management Disease Background and Overview
6. Postoperative Pain Management Patient Journey
7. Postoperative Pain Management Epidemiology and Patient Population
8. Postoperative Pain Management Treatment Algorithm, Current Treatment, and Medical Practices
9. Postoperative Pain Management Unmet Needs
10. Key Endpoints of Postoperative Pain Management Treatment
11. Postoperative Pain Management Marketed Products
12. Postoperative Pain Management Emerging Therapies
13. Postoperative Pain Management Seven Major Market Analysis
14. Attribute Analysis
15. Postoperative Pain Management Market Outlook (7 major markets)
16. Postoperative Pain Management Access and Reimbursement Overview
17. KOL Views on the Postoperative Pain Management Market.
18. Postoperative Pain Management Market Drivers
19. Postoperative Pain Management Market Barriers
21. DelveInsight Capabilities
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/post-operative-pain-management-market
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States